Myolex is at the forefront of addressing the clinical unmet needs associated with neuromuscular disorders and muscle wasting diseases through its innovative technology, Electrical Impedance Myography (EIM). This non-invasive, portable device provides a comprehensive and painless assessment of muscle composition and micro-architecture, enabling clinicians to monitor changes in muscle quality effectively. By utilizing high-frequency electrical currents, EIM captures alterations in electrical impedance that occur due to disease, allowing for the early detection of muscle abnormalities, particularly in conditions like Amyotrophic Lateral Sclerosis (ALS) and Duchenne Muscular Dystrophy (DMD). The technology is designed to facilitate at-home measurements, enhancing patient compliance and providing frequent data collection, which is crucial for timely diagnosis and treatment.

The Myolex mScan, powered by EIM, represents a significant advancement in muscle assessment, offering a quantitative and holistic measure of muscle health. It has demonstrated the ability to predict myofiber atrophy and other pathological changes without the need for invasive procedures, thus serving as a potential alternative to traditional imaging techniques like MRI. Furthermore, the device's sensitivity and reliability make it an invaluable tool for clinical researchers, enabling smaller and faster clinical trials by allowing for targeted measurements of specific muscle groups. This capability not only enhances the accuracy of monitoring disease progression but also empowers patients by providing them with the means to track their muscle condition from the comfort of their homes.

United States

Myolex is disrupting how to measure muscle wasting (and treatment), caused by obesity drugs, aging, and sport injuries. Myolex® EIM is a patented device technology and SaaS data analytics platform that is built to disrupt skeletal muscle measurement by becoming the clinical and wellness standard to aid in the diagnosis and treatment of obesity drug and age-related muscle wasting. 

Myolex has developed the 1st quantitative, sensitive, painless, portable for home use muscle quality assessment device that is specifically designed to non-invasively, comprehensibly, and precisely detect and monitor single muscle wasting.

Myolex

Company Details